𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Androgen deprivation therapy and cardiovascular risk in patients with prostate cancer

✍ Scribed by Zapatero, A.; González San Segundo, C.; Boladeras, A.; Gomez Caamaño, A.; Lopez Torrecilla, J.; Maldonado, X.


Book ID
123595605
Publisher
Wielkopolskie Centrum Onkologii
Year
2013
Tongue
Polish
Weight
56 KB
Volume
18
Category
Article
ISSN
1507-1367

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Androgen deprivation therapy increases c
✍ Christopher S. Saigal; John L. Gore; Tracey L. Krupski; Janet Hanley; Matthias S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract ## BACKGROUND. The use of androgen deprivation therapy (ADT) in the treatment of men with prostate cancer has risen sharply. Although cardiovascular disease is the most common reason for death among men with prostate cancer who do not die of the disease itself, data regarding the effec